Pharmacy World & Science

, 31:696 | Cite as

Clinical pharmacy services in an Iranian teaching hospital: a descriptive study

  • Simin Dashti-Khavidaki
  • Hossein Khalili
  • Hadi Hamishekar
  • Sheida Shahverdi
Research Article


Objective To understand the types of services provided by Iranian clinical pharmacists in nephrology and infectious disease wards, the acceptance rate of clinical pharmacy services in these wards by physicians and the clinical significance of these services in the main teaching hospital in Iran. Setting: Nephrology and infectious disease departments of a university hospital in Iran. Methods During a 12-month prospective data gathering phase, details of all clinical pharmacy services in the nephrology and infectious disease wards of a large university hospital were recorded in the pharmacotherapy monitoring forms. Significance impact of clinical pharmacists’ services was assessed according to the guidelines of The Society of Hospital Pharmacists of Australia. Main outcome measure: Number and type of services provided. Results During 1 year, clinical pharmacists contributed to 1,386 services for 1,105 patients who were admitted in these two wards; of these services, about 95% were accepted by the physicians and about half of them were of moderate-to-life saving clinical significance. Also at least 32% of services were considered to reduce the cost of drug therapy. Conclusions These results support the importance of clinical pharmacists’ participation in health care team rounds to improve the overall quality of medication therapy, enhance patient care and outcome and reduce drug costs to patients and society.


Clinical pharmacist Clinical pharmacy services Iran 



The Authors appreciate the helpful comments of Professor Michael Dooley from Monash University, Australia.


No special funding was obtained for this research.

Conflict of interest

The authors have no conflicts of interest to declare.


  1. 1.
    Schumock GT, Butter MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL, et al. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy. 2003;23(1):113–32.CrossRefPubMedGoogle Scholar
  2. 2.
    Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2003;57(4):513–21.CrossRefGoogle Scholar
  3. 3.
    Clavert RT. Clinical pharmacy—a hospital perspective. Br J Clin Pharmacol. 1999;47(3):231–8.CrossRefGoogle Scholar
  4. 4.
    Plumridge RJ, Wojnar-Horton RE. A review of the pharmacoeconomics of pharmaceutical care. Pharmacoeconomics. 1998;14(2):175–89.CrossRefPubMedGoogle Scholar
  5. 5.
    George B, Silcock J. Economic evaluation of pharmacy services—fact or fiction? Pharm World Sci. 1999;21(4):147–51.CrossRefPubMedGoogle Scholar
  6. 6.
    Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total costs of care in United States hospitals. Pharmacotherapy. 2000;20(6):609–21.CrossRefPubMedGoogle Scholar
  7. 7.
    Plam DQ. Evaluating the impact of clinical interventions by Pharm D students on internal medicine clerkships: the results of a 3 year study. Ann Pharmacother. 2006;40:1541–5.CrossRefGoogle Scholar
  8. 8.
    Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. An economic analysis of a randomized, controlled, multicentre study on clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Pharmacotherapy. 2000;20(10):1149–58.CrossRefPubMedGoogle Scholar
  9. 9.
    Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):659–700.CrossRefGoogle Scholar
  10. 10.
    Roberts MS, Stockes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51(3):257–65.CrossRefPubMedGoogle Scholar
  11. 11.
    Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned readmissions and out-of-hospital death. J Am Geriatr Soc. 1998;46(2):174–80.PubMedGoogle Scholar
  12. 12.
    McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999;159(19):2306–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Dooley MJ, Bogovic A, Carroll M, Cuell S, Galbraith K, Matthews H. SHPA standards of practice for clinical pharmacy: SHPA committee of specialty practice in clinical pharmacy. J Pharm Pract Res. 2005;35(2):122–46.Google Scholar
  14. 14.
    Charpiat B, Conort O, Rose FX, Escofier L, Juste M, Roubille R, et al. Assessment of clinical pharmacists’ interventions in French hospitals: results of a multicenter study. Ann Pharmacother. 2008;42(7):1095–103.CrossRefPubMedGoogle Scholar
  15. 15.
    Leape LL, Cullen D, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation in physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;281(3):267–70.CrossRefGoogle Scholar
  16. 16.
    Bates DW, Leape LL, Cullen DJ, Larid N, Petersen LA, Teich JM. Effects of computerized physician order entry and a team intervention on prevention of serous medication errors. JAMA. 1998;280:1311–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Dale A, Copeland R, Barton R. Prescribing errors on medical wards and the impact of clinical pharmacists. Int J Pharm Pract. 2003;11:19–24.CrossRefGoogle Scholar
  18. 18.
    Bosma L, Jansman FGA, Franken AM, Harting JW, Van Den Bemt PMLA. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci. 2008;30(1):31–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Brown C. Physicians acceptance of drug-therapy recommendations using a written data and communications form. Consult Pharm. 1991;6:729–34.Google Scholar

Copyright information

© Government Employee 2009

Authors and Affiliations

  • Simin Dashti-Khavidaki
    • 1
  • Hossein Khalili
    • 2
  • Hadi Hamishekar
    • 3
  • Sheida Shahverdi
    • 4
  1. 1.Clinical Pharmacy, Department of Nephrology, Imam HospitalTehran University of Medical SciencesTehranIran
  2. 2.Clinical Pharmacy, Department of Infectious Disease, Imam Hospital, School of PharmacyTehran University of Medical SciencesTehranIran
  3. 3.Resident of Clinical Pharmacy, School of PharmacyTehran University of Medical Sciences/Tabriz University of Medical SciencesTehranIran
  4. 4.School of PharmacyTehran University of Medical SciencesTehranIran

Personalised recommendations